151 related articles for article (PubMed ID: 30900517)
41. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
[TBL] [Abstract][Full Text] [Related]
42. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
[TBL] [Abstract][Full Text] [Related]
43. A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.
Zhao S; Liu W; Li S; Shi T; Chen Q; Li Q; Sun L; Ren D; Song Z; Huang C; Xu S
Cancer Res Treat; 2021 Apr; 53(2):601-606. PubMed ID: 33091968
[TBL] [Abstract][Full Text] [Related]
44. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ
J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259
[TBL] [Abstract][Full Text] [Related]
45. Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.
Chennouf A; Arslanian E; Roberge D; Berthelet F; Bojanowski M; Bahary JP; Masucci L; Belanger K; Florescu M; Wong P
Cureus; 2017 Mar; 9(3):e1068. PubMed ID: 28409069
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory myofibroblastic tumor of the uterus - case report.
Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
[TBL] [Abstract][Full Text] [Related]
47. TNS1-ALK Fusion in a Recurrent, Metastatic Uterine Mesenchymal Tumor Originally Diagnosed as Leiomyosarcoma.
Lee J; Singh A; Ali SM; Lin DI; Klempner SJ
Acta Med Acad; 2019 Apr; 48(1):116-120. PubMed ID: 31264439
[TBL] [Abstract][Full Text] [Related]
48. A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate.
Owusu-Brackett N; Johnson R; Schindel DT; Koduru P; Cope-Yokoyama S
Cancer Genet; 2013; 206(9-10):353-6. PubMed ID: 24290361
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary inflammatory myofibroblastic tumor after Hodgkin's lymphoma and application of PET imaging.
Howman-Giles R; London K; McCowage G; Graf N; Harvey J
Pediatr Surg Int; 2008 Aug; 24(8):947-51. PubMed ID: 18528695
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and treatment of inflammatory myofibroblastic tumor of the chest].
Zhang J; Wang Y; Chu X; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):135-8. PubMed ID: 22366025
[TBL] [Abstract][Full Text] [Related]
51. A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature.
Satomi T; Watanabe M; Matsubayashi J; Nagao T; Chiba H
Med Mol Morphol; 2010 Sep; 43(3):185-91. PubMed ID: 20857269
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior.
Sethi B; Pai T; Allam A; Epari S
Indian J Pathol Microbiol; 2015; 58(4):509-12. PubMed ID: 26549078
[TBL] [Abstract][Full Text] [Related]
53. Infratemporal inflammatory myofibroblastic tumour with orbital extension.
Chow SP; Nastri A; Hardy T
Clin Exp Ophthalmol; 2010 Oct; 38(7):727-30. PubMed ID: 20497435
[TBL] [Abstract][Full Text] [Related]
54. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
55. Pediatric Inflammatory Myofibroblastic Tumors of the Airway: Two Case Reports with Varying Clinical Presentation.
Kumar N; Saravanamuthu T; Srinivasan A; Raman T; Scott JX
Iran J Otorhinolaryngol; 2018 May; 30(98):171-176. PubMed ID: 29876333
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
[TBL] [Abstract][Full Text] [Related]
58. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
59. ALK-1 positive orbital inflammatory myofibroblastic tumour (IMT) associated with prominent numbers of IgG4 plasma cells - a case report.
Mudhar HS; Nuruddin M
Orbit; 2013 Oct; 32(5):321-3. PubMed ID: 23927068
[TBL] [Abstract][Full Text] [Related]
60. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
